Koortslipcrème Aciclovir Da

Aciclovir, the active ingredient in Koortslipcrème Aciclovir Da, is an antiviral presented as a cream for topical use. It treats herpes labialis (cold sores) and other herpes simplex skin infections in both adults and children.

GNH USA supplies Koortslipcrème Aciclovir Da as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Aciclovir cream acts locally on herpes simplex virus infections of the skin and mucous membranes.

- Herpes labialis (cold sores): shortens lesion duration and reduces pain. - Herpes simplex skin infections: promotes healing of facial or neck lesions. - Recurrent herpes simplex outbreaks: helps manage and limit new lesions when applied at the first sign of infection.

Topical aciclovir is generally well tolerated, but local reactions can occur.

Common Side Effects: - Mild burning or stinging at the application site. - Itching or mild rash. - Redness or erythema. - Dryness or peeling of the skin. - Local tenderness. - Slight swelling.

Serious or Rare Side Effects: - Allergic contact dermatitis. - Severe skin irritation or ulceration. - Angioedema or facial swelling. - Systemic hypersensitivity reactions. - Unexpected fever or malaise. - Rare systemic absorption leading to renal effects.

When using Koortslipcrème Aciclovir Da, consider the following safety measures.

- Application area: limit use to affected skin only. - Duration of therapy: follow prescriber instructions, typically up to 5‑10 days. - Age restrictions: consult a healthcare professional before use in children under 12 months. - Concomitant skin products: avoid using other medicated creams on the same area unless advised. - Pregnancy and breastfeeding: discuss risks with a physician before use. - Store at below 25°C: keep in the original tube, protect from moisture and direct sunlight.

Aciclovir cream may interact with other topical agents or systemic antivirals.

Major Interactions (Avoid): - Concurrent use with other topical antivirals: may increase local irritation. - Simultaneous systemic aciclovir therapy: could raise systemic exposure. - Use with chemotherapy agents: may impair wound healing.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce antiviral efficacy. - Topical anesthetics: may mask irritation signs. - Use with sunscreen: may increase photosensitivity. - Co‑application with moisturizers containing alcohol: may cause dryness. - Combination with other irritant creams: monitor for excessive redness.